Cervical Mosaic and an Integrated Pathophysiological Approach to Early Cervical Neoplasia
Recombinant Human Tumor Necrosis Factor Depresses Serum Iron in Mice
Preliminary Clinical Trial of Immunotherapy for Malignant Glioma
Role of In Vivo Scavenger Function of Macrophages in Priming for Endogenous Production of Tumor Necrosis Factor
Endogenous Production of Tumor Necrosis Factor in Normal Mice and Human Cancer Patients by Interferons and Other Cytokines Combined with Biological Response Modifiers of Bacterial Origin
Augmented Antitumor Effect of Combined Human Natural Interferon-Alpha and Mismatched Double-Stranded RNA Treatment Against a Human Malignant Melanoma Xenograft
Enhancement of the Specific Cytotoxicity of a Breast Cancer-Associated Antigen Immunotoxin by the Carboxylic Ionophore Monensin
In Vivo Myelosuppression by Combination Interferon Treatment : Antagonism of MuIFN-γ and MuIFN-β Myelosuppressive Effects
Preparation and Antitumor Effect of Macrophage Activating Factor (MAF) Encapsulated in Liposomes Bearing a Monoclonal Anti-Human Melanoma (A375) Antibody
Announcement : Second Conference on Immunity to Cancer, Williamsburg, Virginia, November 9-11, 1987